Saturday, July 11, 2026

Drug profile · INN

nonoxynol-9

nonoxynol-9 (TODAY) is a cell membrane disrupting agent. Route of administration: vaginal. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — nonoxynol-9
US status
approved
Class
Route
VAGINAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

nonoxynol-9 (TODAY) is a cell membrane disrupting agent. Route of administration: vaginal. Current US regulatory status: approved.

Key facts

INN nonoxynol-9
Brand TODAY
Mechanism Cell membrane disrupting agent
Target Cell membrane
Route VAGINAL
Formulation AEROSOL

Mechanism of action

Cell membrane disrupting agent

Primary target: Cell membrane

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. colistimethate sodium Antiinfectives for systemic use (J01)
  2. daptomycin Antiinfectives for systemic use (J01)
  3. candicidin Cell membrane inhibitor
  4. chlorhexidine gluconate Cell membrane inhibitor
  5. deoxycholic acid Cell membrane disrupting agent
  6. gramicidin Cell membrane inhibitor

Frequently asked questions

What is nonoxynol-9?

nonoxynol-9 (TODAY) is a cell membrane disrupting agent. Route of administration: vaginal. Current US regulatory status: approved.

What is the brand name for nonoxynol-9?

TODAY is a marketed brand name for nonoxynol-9. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of nonoxynol-9?

nonoxynol-9 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.